PAREXEL Introduces Executive Briefing Series On Proven Practices To Assist Emerging and Mid-size Biopharma In Achieving Better Outcomes

To help emerging and mid-size biopharmaceutical companies address an increasingly challenging regulatory and commercial environment, PAREXEL is introducing a series of executive briefings with clinical operations and outsourcing leaders worldwide.  During these forums, PAREXEL will discuss how a spectrum of proven operating practices and relationship models can significantly reduce timelines and costs and streamline protocols and programs. Read more…